The Effects of Two Anesthetic Drugs on Some Enzyme Levels in Patients Undergoing Lower Extremity Surgery

NCT ID: NCT05950555

Last Updated: 2023-08-31

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 90 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2021-12-30
• Study Completion Date: 2023-05-28

Brief Summary

The primary aim of this study was to compare the effects of dexmedetomidine and ketamine, which are administered intravenously during surgery, on the levels of malondialdehyde, an antioxidant, anti-inflammatory enzyme, heme oxygenase-1 enzyme levels and C-reactive protein levels in patients who underwent lower extremity surgery under combined spinal epidural anesthesia.

Detailed Description

This study was planned as double-blind; The researcher who evaluated the patient and recorded the data did not know which group the patient belonged to. The randomization sequence was generated with a computerized random number generator and patients were assigned to 3 groups, with 30 patients in each group.

The group to which the patient was included was listed in serially numbered sealed opaque envelopes. Another investigator (not involved in this study and not blinded to group assignment) administered CSEA to patients in a sitting position and opened the envelopes to see which group the patient belonged to, and prepared and administered the drugs to be used during anesthesia. An anesthetist, blinded to the group allocation, was responsible for collecting the intraoperative data. During and after surgery, data were recorded by and by this investigator. The blood of the patients was taken by the researcher who collected the data and delivered to the researchers who made the biochemical analyzes of their blood and blinded the groups. All surgeries were performed by the same surgical team and the same anesthesia team.

Peripheral IV vascular access was established using a 16/18-gauge cannula on the day of the operation. No premedication was applied to any patient before the operation. Before the anesthesia procedure, the patients' age, weight, height, body mass indexes, american society of anesthesiologists (ASA) physical status, systolic, diastolic and mean blood pressure baseline values, heart rate and oxygen saturation levels were recorded.

CSEA was applied to all patients in the sitting position. Following skin sterilization and local anesthetic infiltration (2% lidocaine), an 18-gauge Tuohy needle (CSEA, Braun, Melsungen, Germany) was advanced along the midline L3-4 or L4-5 intervertebral spaces using a loss of resistance technique. After negative pressure was detected, a 27-gauge pen-tipped spinal needle was inserted intrathecally using the needle-through-the-needle technique. After the free cerebrospinal fluid flow was observed, 1.8 ml 0.5% isobaric bupivacaine (9 mg) and 15 µg fentanyl were administered for 30 seconds. Then, the spinal needle was removed and the catheter was inserted into the epidural space, and it was advanced 3-5 cm in the space and controlled with negative pressure, and the catheter was fixed. At the end of the anesthesia procedure, the patients were placed in the supine position for the operation. The necessary study drugs were started to be administered to the patients in accordance with the study group they were assigned to, and infusions were continued throughout the operation.

The level of sensory block was assessed with the pinprick test, and surgery was allowed when the sensory block reached the upper level of the T12-L1 dermatome. If sensory block did not occur within the first 20 minutes following the spinal injection, spinal anesthesia was considered unsuccessful and the patients were excluded from the study. The patients who were excluded from the study were injected with an additional 5 ml of 2% lidocaine solutions through the epidural catheter until the sensory block T12-L1 level was achieved, and the patients were allowed to operate.

If the intrathecal space could not be reached in three unsuccessful attempts, a general anesthesia protocol was planned and patients requiring general anesthesia were excluded from the study.

For the measurement of MDA and HO-1 levels, blood samples taken from the patient groups included in the study were taken for 10-20 minutes for clotting. After the tube was kept in an upright position, it was centrifuged at +4°C at 4000 rpm for 15 minutes. The serum samples obtained were aliquoted and placed in a deep freezer at -80˚Ϲ and kept there until the day of analysis.

Serum malondialdehyde (MDA) and HO-1 levels were measured on the same day in order not to be affected by the variation between days. Serum MDA and HO-1 levels were determined by ELISA method, using "Human MDA ELISA Kit" and Human HO-1 ELISA Kit. measured in accordance with the manufacturer's instructions.

In addition, C-reactive protein (CRP) (mg/dl), calcium (mg/dl), alkaline phosphatase (U/L), lactate dehydrogenase (U/L), aspartate aminotransferase (U/L), alanine aminotransferase, which are routinely checked at preoperative, postoperative 2nd and 24th hours. (U/L), glucose (mg/dl), potassium (nmol/L), iron (ug/dl), total protein (g/dl) and albumin (g/dl) levels in Beckman Coulter device, ferritin (ng) /ml) Beckman Coulter device, Blood count parameters, White Blood Cell Count (10^3/mcL), Total Lymphocyte Count (10^3/mcL), Hemoglobin (g/dL) were studied on Sysmex device.

Conditions

Malondialdehyde; Heme Oxygenase; C-Reactive Protein

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: SINGLE

Study Groups

Patients given saline

10 cc/hour isotonic is given throughout the operation.

Group Type: ACTIVE_COMPARATOR

Saline

Intervention Type: OTHER

We used 0.9% isotonic sodium chloride.

Patients given dexmedetomidine.

Dexmedetomidine 0.1 µg/kg IV bolus followed by 0.2 µg/kg/hr infusion throughout surgery.

Group Type: ACTIVE_COMPARATOR

Dexmedetomidine

Intervention Type: OTHER

We used the vial containing 200 mcg/2 ml i.v. concentrated infusion solution in 100 ml of 0.9% isotonic sodium chloride.

Patients given ketamine.

Ketamine 0.2 mg/kg bolus followed by 0.1 mg/kg/hr infusion throughout surgery.

Group Type: ACTIVE_COMPARATOR

Ketamine

Intervention Type: OTHER

We used 500 mg/10 ml solution for injection in 0.9% isotonic sodium chloride.

Interventions

Saline

We used 0.9% isotonic sodium chloride.

Intervention Type: OTHER

Dexmedetomidine

We used the vial containing 200 mcg/2 ml i.v. concentrated infusion solution in 100 ml of 0.9% isotonic sodium chloride.

Intervention Type: OTHER

Ketamine

We used 500 mg/10 ml solution for injection in 0.9% isotonic sodium chloride.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• ASA risk classification 1-2
• Patients who agreed to participate in the study

Exclusion Criteria

• Body mass index (BMI) over 30 kg/m2
• Patients who will use bone cement in the surgical procedure
• Patients who will apply a tourniquet to the lower extremity
• Patients with vascular and coronary disease
• Patients with coagulation disorders that would prevent the application of CSEA
• Patients with allergies to the drugs to be used in the study
• Patients with increased head and intraocular pressure
• Patients with psychiatric and neuromuscular disorders
• Patients with multiple trauma
• Patients who did not consent to participate in the study

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Ataturk University

OTHER

Sponsor Role: lead

Responsible Party

Mehmet AKSOY

Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

İrfan Uç

Role: PRINCIPAL_INVESTIGATOR

Research Assistant

Locations

Ataturk University

Erzurum, , Turkey (Türkiye)

Countries

Turkey (Türkiye)

Other Identifiers

B.30.2.ATA.0.01.00/23

Identifier Type: -

Identifier Source: org_study_id